Hydroxychloroquine for COVID-19: Not Ready for Prime-Time - Frankly Speaking EP 188Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato
A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.
Already listened on another platform?
- Identify the limitations of using hydroxychloroquine for COVID-19
- Discuss with patients why hydroxychloroquine is best used for COVID-19 in the setting of a clinical trial
- Recognize the possible adverse effects of hydroxychloroquine
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Alan M. Ehrlich, MD, FAAFP
Associate Professor of Family Medicine and Community Health, University of Massachusetts Medical School
Executive Editor, DynaMed
Supporters and Partners